AORTIC STENOSIS: Progressive Obstruction of Left Ventricular Outflow Leading to Pressure Overload
Aortic stenosis (AS) is a progressive narrowing of the aortic valve opening, resulting in obstruction of blood flow from the left ventricle into the aorta. As the valve becomes thickened, calcified or fused, the ventricle must generate increasingly high pressures to overcome the narrowed outflow tract. Over time, this sustained pressure overload leads to concentric left ventricular hypertrophy, reduced compliance, impaired filling and eventually heart failure. Although AS can develop at any age, it is most commonly seen in older adults due to age-related calcification of the valve. In younger people, congenital bicuspid aortic valves or rheumatic heart disease are important causes. The disease often progresses silently for years before classic symptoms (angina, syncope and dyspnoea) emerge, signalling advanced and clinically significant obstruction.
What You Need to Know
Aortic stenosis is a progressive narrowing of the aortic valve that obstructs blood flow from the left ventricle into the systemic circulation during systole. Under normal conditions, the aortic valve opens fully, offering minimal resistance to ejection. When the valve leaflets become thickened, calcified, or immobile, the effective valve area decreases and resistance to outflow rises. To overcome this obstruction and maintain stroke volume, the left ventricle must generate markedly higher systolic pressures, placing it under sustained pressure overload.
The left ventricle initially adapts by developing concentric hypertrophy, where the ventricular wall thickens without significant chamber dilation. This adaptation reduces wall stress and helps preserve systolic function in the early stages of disease. However, the hypertrophied myocardium becomes stiff and less compliant, impairing diastolic filling and raising left ventricular end-diastolic pressure. As a result, filling becomes increasingly dependent on adequate diastolic time and atrial contribution, making the circulation more vulnerable to tachycardia or loss of coordinated atrial contraction.
Several key pathophysiological consequences drive symptom development:
Severe pressure overload requiring high intraventricular pressures to eject blood across the narrowed valve.
Concentric left ventricular hypertrophy that preserves systolic function but reduces diastolic compliance.
Impaired coronary perfusion as myocardial oxygen demand increases while diastolic coronary filling becomes compromised.
Over time, compensatory mechanisms fail. Stroke volume and cardiac output decline, particularly during exertion when the ventricle cannot increase flow across the fixed obstruction. Coronary perfusion becomes inadequate because the hypertrophied myocardium has high oxygen demand while elevated ventricular pressures and shortened diastole limit coronary blood flow. The classic triad of exertional chest pain, syncope, and heart failure reflects this imbalance between myocardial demand and supply and signals advanced disease with limited cardiac reserve.
Beyond the Basics
Structural Causes and Progressive Valve Narrowing
Aortic stenosis develops when structural changes to the aortic valve restrict leaflet opening during systole. In older adults, age-related degenerative disease is the most common cause. Repeated mechanical stress on the valve leaflets triggers chronic inflammation, lipid deposition, and progressive calcification. Calcium nodules accumulate within the leaflets, reducing flexibility and preventing full excursion. What begins as mild restriction gradually progresses to a markedly narrowed orifice with fixed resistance to outflow.
Congenital bicuspid aortic valves are an important cause in younger individuals. With only two leaflets instead of three, mechanical stress is unevenly distributed across the valve. This accelerates endothelial injury, fibrosis, and calcification, often leading to clinically significant stenosis decades earlier than in tricuspid valves. Rheumatic heart disease produces a different pattern of injury, characterised by leaflet thickening, commissural fusion, and scarring that narrows the valve opening and limits mobility. Despite differing aetiologies, all forms of aortic stenosis share a common endpoint of progressive valve narrowing and increasing resistance to left ventricular ejection.
Pressure Overload and Concentric Hypertrophy
As the valve area decreases, the left ventricle must generate progressively higher systolic pressures to maintain forward flow. This chronic pressure overload stimulates concentric hypertrophy, where myocardial wall thickness increases without significant chamber dilation. Initially, this adaptation reduces wall stress and preserves ejection fraction, allowing cardiac output to remain relatively stable at rest.
Over time, the hypertrophied myocardium becomes stiff and less compliant. Diastolic filling is impaired, and left ventricular end-diastolic pressure rises. Ventricular filling becomes increasingly dependent on adequate diastolic time and atrial contraction. The thickened myocardium also has increased oxygen demand, while capillary density does not increase proportionally. This mismatch reduces coronary reserve and predisposes the ventricle to subendocardial ischaemia, even in the absence of obstructive coronary artery disease.
The Haemodynamic Consequences of a Fixed Obstruction
Aortic stenosis creates a fixed obstruction to outflow, meaning the heart cannot significantly increase stroke volume during exertion. When metabolic demand rises, the ventricle is unable to augment cardiac output because the narrowed valve limits forward flow. This inability to adapt explains exertional syncope, where transient reductions in cerebral perfusion occur during activity.
Elevated left ventricular end-diastolic pressure is transmitted backward into the left atrium and pulmonary veins. This leads to pulmonary congestion and exertional dyspnoea. At the same time, coronary perfusion is compromised. Coronary blood flow occurs primarily during diastole, but high intraventricular pressures and shortened diastolic time reduce the pressure gradient driving coronary flow. Combined with increased myocardial oxygen demand, this results in angina, even when coronary arteries are anatomically normal.
Late-Stage Decompensation and Clinical Deterioration
As compensatory mechanisms fail, left ventricular systolic function begins to decline. Stroke volume falls, pulmonary pressures rise further, and symptoms of heart failure become more prominent. Patients may develop fatigue, orthopnoea, paroxysmal nocturnal dyspnoea, and signs of pulmonary congestion. In advanced disease, reduced forward flow can also contribute to peripheral hypoperfusion and systemic congestion.
Once symptoms appear, the natural history of aortic stenosis changes markedly. Survival without intervention declines sharply because the ventricle can no longer compensate for the fixed obstruction. Disease progression may be gradual and asymptomatic for years, which is why regular monitoring is essential. The onset of symptoms signals a critical stage where valve intervention becomes necessary to prevent irreversible ventricular dysfunction and death.
Clinical Connections
Severe aortic stenosis becomes clinically apparent once the left ventricle can no longer compensate for the fixed outflow obstruction. The classic triad of angina, syncope, and dyspnoea results from advanced disease is commonly associated with a poor prognosis. Angina arises from the imbalance between increased myocardial oxygen demand and reduced coronary perfusion, syncope occurs when cardiac output cannot rise during exertion, and dyspnoea results from rising left-sided filling pressures and pulmonary congestion.
On examination, a harsh systolic ejection murmur best heard at the right upper sternal border and radiating to the carotids is characteristic, along with a slow-rising carotid pulse and a displaced apex beat indicating ventricular hypertrophy.
Certain clinical findings should prompt concern for disease progression:
Exertional chest pain or dizziness, indicating limited ability to augment cardiac output.
New or worsening breathlessness, suggesting rising filling pressures or developing heart failure.
Evidence of left ventricular decompensation, such as pulmonary crackles or declining exercise tolerance.
Echocardiography is central to diagnosis and follow-up, as it quantifies aortic valve area, transvalvular pressure gradients, and left ventricular systolic and diastolic function. Serial imaging allows identification of progression from compensated hypertrophy to ventricular dysfunction. Management is guided by symptom burden and disease severity. Medical therapy may provide temporary symptom relief but does not halt disease progression.
Definitive treatment requires valve intervention, either surgical aortic valve replacement or transcatheter aortic valve implantation, depending on patient risk profile and anatomical suitability. Careful monitoring before and after intervention is essential, as timely valve replacement before irreversible ventricular dysfunction develops is a key determinant of outcome.
Concept Check
Why does the left ventricle undergo concentric hypertrophy in aortic stenosis?
What structural changes occur in the valve leaflets during age-related degenerative stenosis?
Why does exertional syncope occur in patients with severe aortic stenosis?
How does aortic stenosis impair coronary perfusion even when coronary arteries are normal?
Why is the onset of symptoms an important marker in the progression of aortic stenosis?